Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Prognostic Value of IPSS-R Score, Cytogenetic Aberrations, and Cytopenias on Outcome of Allogeneic Hematopoietic Stem Cell Transplant in Myelodysplastic Syndrome in GATA2 Deficiency

Julia Scheiermann, MD, Robert West, PhD, Lisa J. Embree, PhD, Katherine R. Calvo, MD PhD, Nirali N. Shah, MD, Laura Tuschong, PhD, Mark Parta, MD, Dennis D. Hickstein, MD

Blood (2018) 132 (Supplement 1): 3094.

https://doi.org/10.1182/blood-2018-99-114874

Published: 2018

Journal Articles

Allogeneic Hematopoietic Stem-Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen

Steven M. Holland, MD, Kristin Baird, Mark Parta, MD, Hind Rafei, MD, Nirali N Shah, MD, Kristen Cole, B.S.

Blood (2017) 130 (Supplement 1): 2447.

https://doi.org/10.1182/blood.V130.Suppl_1.2447.2447

Published: 2017

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Deficiency

Dennis D. Hickstein, MD, Nirali N Shah, MD, Alexandra F Freeman, MD, Christa Zerbe, MD, Steven M. Holland, MD, Mark Parta, MD

Blood (2015) 126 (23): 1214.

https://doi.org/10.1182/blood.V126.23.1214.1214

Published: 2015

Journal Articles

Haploidentical Transplantation for DOCK8 Deficiency

Nirali N Shah, MD, Alexandra F Freeman, MD, Mark Parta, MD, Helen Su, MD PhD, Gulbu Uzel, MD, Juan C. Gea-Banacloche, MD, Steven M. Holland, MD, Dennis D. Hickstein, MD

Blood (2015) 126 (23): 2229.

https://doi.org/10.1182/blood.V126.23.2229.2229

Published: 2015

Journal Articles

Nonmyeloablative Versus Myeloablative Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Deficiency

Jennifer Cuellar-Rodriguez, MD, Dennis D. Hickstein, MD, Jennifer K. Grossman, MD BSc, Mark Parta, MD, Juan Gea-Banacloche, MD, Christa S. Zerbe, MD, Alexandra F Freeman, MD, Steven M. Holland, MD, Katherine R. Calvo, MD, PhD

Blood (2014) 124 (21): 1247.

https://doi.org/10.1182/blood.V124.21.1247.1247

Published: 2014

Journal Articles

The Use Of a Novel Nonmyeloablative Conditioning Regimen and Sirolimus For GvHD Prophylaxis To Transplant Patients With Chronic Granulomatous Disease

Elizabeth M. Kang, MD, Harry Malech, MD, Dianne Hilligoss, Martha Marquesen, Corin Kelly, Mark Parta, MD

Blood (2013) 122 (21): 2157.

https://doi.org/10.1182/blood.V122.21.2157.2157

Published: 2013

NARROW

Prognostic Value of IPSS-R Score, Cytogenetic Aberrations, and Cytopenias on Outcome of Allogeneic Hematopoietic Stem Cell Transplant in Myelodysplastic Syndrome in GATA2 Deficiency

Allogeneic Hematopoietic Stem-Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen

Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Deficiency

Haploidentical Transplantation for DOCK8 Deficiency

Nonmyeloablative Versus Myeloablative Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Deficiency

The Use Of a Novel Nonmyeloablative Conditioning Regimen and Sirolimus For GvHD Prophylaxis To Transplant Patients With Chronic Granulomatous Disease

Email alerts

ASH Publications

American Society of Hematology

Prognostic Value of IPSS-R Score, Cytogenetic Aberrations, and Cytopenias on Outcome of Allogeneic Hematopoietic Stem Cell Transplant in Myelodysplastic Syndrome in GATA2 Deficiency

Allogeneic Hematopoietic Stem-Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen

Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Deficiency

Haploidentical Transplantation for DOCK8 Deficiency

Nonmyeloablative Versus Myeloablative Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Deficiency

The Use Of a Novel Nonmyeloablative Conditioning Regimen and Sirolimus For GvHD Prophylaxis To Transplant Patients With Chronic Granulomatous Disease

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only